A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer
NCT04086875 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 332
Last updated 2024-06-10
Summary
This trial studies how well a text-based intervention works in improving adherence to hormone therapy in patients with stage I-III hormone receptor positive breast cancer. Women often require long term therapy with adjuvant hormone therapy to prevent the cancer from returning and to improve overall survival. Side effects from hormone therapy may prevent some women from staying adherent to their medication therapy. A text-based intervention may provide educational information to breast cancer patients who are undergoing adjuvant hormone therapy.
Conditions
- Anatomic Stage I Breast Cancer AJCC v8
- Anatomic Stage IIA Breast Cancer AJCC v8
- Anatomic Stage IA Breast Cancer AJCC v8
- Anatomic Stage II Breast Cancer AJCC v8
- Anatomic Stage III Breast Cancer AJCC v8
- Anatomic Stage IIIA Breast Cancer AJCC v8
- Anatomic Stage IIB Breast Cancer AJCC v8
- Anatomic Stage IIIB Breast Cancer AJCC v8
- Anatomic Stage IIIC Breast Cancer AJCC v8
- Estrogen Receptor Positive Tumor
- Progesterone Receptor Positive Tumor
- Prognostic Stage I Breast Cancer AJCC v8
- Prognostic Stage IA Breast Cancer AJCC v8
- Prognostic Stage IB Breast Cancer AJCC v8
- Prognostic Stage II Breast Cancer AJCC v8
- Prognostic Stage IIA Breast Cancer AJCC v8
- Prognostic Stage IIB Breast Cancer AJCC v8
- Prognostic Stage III Breast Cancer AJCC v8
- Prognostic Stage IIIA Breast Cancer AJCC v8
- Prognostic Stage IIIB Breast Cancer AJCC v8
- Prognostic Stage IIIC Breast Cancer AJCC v8
Interventions
- BEHAVIORAL
-
Focus Group
Participate in focus group
- OTHER
-
Text Message
Receive text messages
- OTHER
-
Best Practice
Receive usual care
- OTHER
-
Questionnaire Administration
Ancillary studies
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Thomas Jefferson University
lead OTHER
Principal Investigators
-
Kuang-Yi Wen, MD · Sidney Kimmel Cancer Center at Thomas Jefferson University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-11-07
- Primary Completion
- 2024-09-24
- Completion
- 2024-09-24
Countries
- United States
Study Locations
More Related Trials
-
A Feasibility Trial of a Web Based App Intervention in Hormone Positive Breast Cancer Patients to Improve Adherence to Endocrine Therapy
NCT05488145 ·Status: TERMINATED ·Phase: NA
-
Compliance to a Hormone Therapy Regimen in Breast Cancer
NCT00666822 ·Status: COMPLETED
-
Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer
NCT02400060 ·Status: COMPLETED ·Phase: NA
-
Impact of Web Application Support Versus Standard Management on Compliance With Adjuvant Hormone Therapy at 18 Months in Patients Treated for Breast Cancer
NCT04554927 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Improving Adherence to EHT Among Breast Cancer Patients
NCT02850939 ·Status: COMPLETED ·Phase: NA
-
Adherence of Hispanic / Latina Breast Cancer - Patients to Adjuvant Aromatase Inhibitors
NCT03144037 ·Status: COMPLETED
-
Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study
NCT05568472 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
SMS Reminders to Improve Medication Adherence of Aromatase Inhibitors
NCT02524548 ·Status: COMPLETED ·Phase: NA
-
Analysis of Initial Adherence and Its Impact on Long-term Adherence to Hormonal Therapy for Breast Cancer
NCT03186599 ·Status: UNKNOWN ·Phase: NA
-
Digital Patient Support Program for Self-efficacy and Medication Adherence in Women on Adjuvant Endocrine Treatment for Breast Cancer
NCT06989450 ·Status: RECRUITING ·Phase: NA
-
Therapeutic Education Intervention in Breast Cancer: PEPs Hormonotherapy
NCT02300675 ·Status: COMPLETED ·Phase: NA
-
Collaborative Research: Multiscale Modeling and Intervention for Improving Long-Term Medication
NCT06865755 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Views and Attitudes of Oncologists and Geriatricians on the Use of Chemotherapy and Hormone Therapy in Treating Older and/or Frail Women With Breast Cancer
NCT00478283 ·Status: COMPLETED ·Phase: NA
-
Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients
NCT06726889 ·Status: RECRUITING
-
Expectations and Side Effects of Endocrine Therapy in Women With Breast Cancer
NCT02088710 ·Status: UNKNOWN
-
Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer
NCT00010140 ·Status: UNKNOWN ·Phase: PHASE3
-
Decision Aids for Tamoxifen Treatment in Breast Cancer Patients
NCT02488603 ·Status: UNKNOWN ·Phase: NA
-
Pilot Study of a an App to Improve Medication Adherence in Breast Cancer Survivors Receiving AIs
NCT04170920 ·Status: COMPLETED ·Phase: NA
-
Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer
NCT00002529 ·Status: COMPLETED ·Phase: PHASE3
-
Geriatric Care Survivorship Intervention for Improving the Overall Health of Older Adults With Stage I-III Breast Cancer Who Have Completed Curative Treatment
NCT05928325 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Geriatric Oncology Assessment and Coping Skills Training for Older Women on Aromatase Inhibitor Therapy
NCT07232056 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Exercise During Chemotherapy in Older Women With Stage I-III Breast Cancer
NCT05025059 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Small-group, Virtual Program for Improving Symptoms and Distress Related to Hormonal Therapy for Breast Cancer Survivors
NCT03837496 ·Status: COMPLETED ·Phase: NA
-
Adherence to Aromatase Inhibitors: The Role of Partners
NCT02753985 ·Status: COMPLETED
-
Writing Interventions in Breast Cancer Patients Taking Aromatase Inhibitors
NCT04651452 ·Status: COMPLETED ·Phase: NA